In a recent study conducted by Liu et al., PFD was reported to demonstrate anti-angiogenic activity in-vitro through VEGF-A/VEGFR-2 and its downstream AKT signaling pathway, so as to retard the wound healing (pro-proliferation) process [67]. The gene discussed is VEGFA; the disease is polyostotic fibrous dysplasia.